Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

To fully realize the benefits of GenAI and leverage it successfully, it’s crucial to develop strategies that harness its full ...

It’s reported that Apple plans to open its on-device AI models to developers at WWDC 2025, aiming to boost app creation and ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

Sanofi (ENXTPA:SAN) recently entered into a multi-year partnership with Viz.ai and Regeneron to develop an AI-powered solution for COPD management, reflecting its focus on innovation. Over the last ...

Regeneron is buying 23andMe for $256M in bankruptcy, gaining access to DNA data from 15 million users to aid drug research.

A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar ...

Equity Insider News Commentary ? The World Economic Forum recently spotlighted five healthcare breakthroughs, and at the top of the list was artificial intelligence. From surgical precision tools to ...